Mental Health & Depression: 66 new trials, 3,254 recruiting, 1,793 papers published, June 15–22, 3628 off-label use reports.
Doctiplus - We are allways here!
Doctiplus - We are allways here!
Mental Health & Depression: 66 new trials, 3,254 recruiting, 1,793 papers published, June 15–22, 3628 off-label use reports.
Cancer & Oncology: 184 new trials, 18,885 recruiting, 5 Phase 3 trials. Off Label Use tops 8,596 reports. June 15–22.
Diabetes: 25 new trials, 1,950 recruiting, 1,472 papers published. Off-label use tops adverse reports at 10,229. June 15–22.
Heart Disease & Cardiovascular: 104 new trials, 8,766 recruiting, 2,369 papers published June 15–22, Fatigue tops adverse reports at 6,625.
Dementia & Alzheimer’s: 10 new trials, 949 recruiting, 1,406 papers published, June 15–22, 628 death reports.
Mental Health & Depression: 77 new trials, 3,241 recruiting, 1,645 papers. Off Label Use tops adverse reports at 3628. June 8–15.
Cancer & Oncology: 218 new trials, 5 Phase 3, 18,821 recruiting, June 8–15, 8596 off-label use reports.
Diabetes: 31 new trials, 1,946 recruiting, 1,389 papers. Off-label use tops adverse reports at 10,224. June 8–15.
Heart Disease & Cardiovascular: 113 new trials, 8,735 recruiting, 2,142 papers published, fatigue tops adverse reports at 6,625, June 8–15.
Dementia & Alzheimer’s: 12 new trials, 942 recruiting, 1,352 papers published, 628 death reports. June 8–15.